Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic properties of topically applied
MTC896 Gel following application of 0.75% (w/w) MTC896 Gel once daily and twice daily and
1.5% (w/w) once daily over 4 weeks in the treatment of acne.